Pharma company ACDIMA is shopping for a new acquisition target, CEO Olfat Ghorab tells Al Borsa. The company’s board of directors has also signed off on new planned investments that will see ACDIMA either add new production lines to its existing capacity or invest in a promising pharma manufacturer, she adds. The state-owned ACDIMA had reportedly acquired United Pharma IV last August in a transaction valued at over EGP 320 mn.
More from Enterprise
The National Bank of Egypt and Banque Misr just hiked rates on CDs — moves that could see the EGP gain against the USD
NBE and BM both hiked rates on CDs by 125…
Miga guarantee unlocks USD 313 mn for National Bank of Egypt trade finance
Plus: Incolease taps securitization market with debut EGP 2 bn…
Here’s why “temporary listings” are all the rage right now
The government plans to list Misr Travel and Egoth in…
Kiwe gets Central Bank green light to launch nationwide
The startup is backed by our friends at EFG Hermes,…